NCT06005519 (AGE) is a NA clinical trial of low AGE diet education in Diabetes Type 2, sponsored by Marmara University Pendik Training and Research Hospital.

Who is sponsoring NCT06005519?

NCT06005519 is sponsored by Marmara University Pendik Training and Research Hospital.

What drugs are being tested in NCT06005519?

Interventions in NCT06005519: low AGE diet education.

What condition does NCT06005519 study?

NCT06005519 studies Diabetes Type 2.

Is NCT06005519 still recruiting?

NCT06005519 is currently completed. Last updated 22 August 2023.

Last reviewed 2023-08-22 · How we verify

NCT06005519: AGE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Short and Long-term Effects of Low Advanced Glycation End Product* Diet

Completed NA Last updated 22 August 2023

What this trial tests

NA trial testing low AGE diet education in Diabetes Type 2 in 60 participants. Completed in 30 August 2021.

Timeline

1 December 2018

Primary endpoint
30 August 2021

30 August 2021

Quick facts

Lead sponsor	Marmara University Pendik Training and Research Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	60
Start date	1 December 2018
Primary completion	30 August 2021
Estimated completion	30 August 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

low AGE diet education

Conditions studied

Diabetes Type 2 — all drugs for Diabetes Type 2 →

Sponsor

Marmara University Pendik Training and Research Hospital

Who can join

Adults 18 to 65, any sex, with Diabetes Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to examine the hypothesis that a diet low in advanced glycation end products (AGE) would provide short and long term improvement in metabolic and inflammatory parameters and serum AGE, Srage, carboxymethyllysine (CML) and methylglyoxal (MG) values in individuals with type 2 diabetes. Specifically, in order to observe the effect of AGE content on the results, diabetic patients who are followed up and who know the principles of low glycaemic index and glycaemic load nutrition suitable for diabetic patients, who do not have additional diseases and who do not smoke were selected. In recent years, it has been determined that AGE accumulation in the tissue has an effect on the pathophysiology of many diseases such as Alzheimer's disease as well as chronic complications of diabetes. However, the contribution of dietary AGE intake to this pool is controversial. There are studies with conflicting results in the literature on whether a low AGE diet is effective on metabolic and biochemical well-being. In addition, studies investigating the effects of reducing AGE content in the diet of people with no chronic disease are limited. In this study, the metabolic results of dietary modification in the short term of 2 weeks and in the long term of 3 months are determined. In addition, the results are analysed separately in type 2 diabetic and non-diabetic groups. Thus, the data showing the short and long term metabolic effects of dietary AGE levels for diabetic and non-diabetic patients will contribute to the literature.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetes Type 2

Currently open trials in the same condition.

NCT07176793 — Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes · recruiting
NCT07485075 — Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical · NA · recruiting
NCT07220213 — FELLAShip to Better Health · NA · recruiting
NCT07350967 — Magnetic Compression Anastomosis Procedure for Partial Jejuno-ileal Diversion: Evaluating the Feasibility of a Novel End · NA · recruiting
NCT07149610 — Connected Care for Type 2 Diabetes Self-Management · NA · recruiting

Other Marmara University Pendik Training and Research Hospital trials

Trials by the same sponsor.

NCT07534956 — The Effect of Paedfusor TCI, Eleveld TCI, and Sevoflurane Anesthesia on Postoperative Awakening Agitation in Pediatric P · NA · recruiting
NCT07305857 — Comparison of the Effects of Target-Controlled Infusion Method and Manual Propofol Administration on Respiratory Functio · NA · not yet recruiting
NCT06994481 — Comparison of the Effects of Endotracheal Intubation and Laryngeal Mask Applications on Optic Nerve Diameter in Pediatri · not yet recruiting
NCT07422467 — Bougie Use for Improving First-Pass Success in Novice Intubators · NA · completed
NCT06994780 — Lung Ultrasound Evaluation of the Effects of PEEP and Recruitment Strategies Adjusted for Intraoperative Dynamic Complia · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06005519 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marmara University Pendik Training and Research Hospital
Last refreshed: 22 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06005519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing